OMX Copenhagen 20 Gains 1.12% as Novo Nordisk Leads Healthcare Stocks Higher

Denmark's benchmark OMX Copenhagen 20 index finished Wednesday's session up 1.12%, with gains in large-cap healthcare and consumer goods companies driving the market higher.

Index Rises on Sector Strength

The advance was led by positive performance in the Healthcare, Consumer Goods, and Oil & Gas sectors, according to closing market data. The gains, however, appeared concentrated in the index's largest constituents.

Market breadth on the broader Copenhagen Stock Exchange was negative, as falling stocks outnumbered advancing ones by a margin of 74 to 50, with 14 issues ending unchanged. This divergence suggests that while the main index posted a solid gain, underlying market sentiment was more mixed.

Top Movers

Healthcare giant Novo Nordisk A/S Class B (CSE:NOVOb) was the session's top performer among blue-chip stocks, climbing 2.64% to close at 301.70.

Ad

Other notable gainers included:

• Coloplast A/S (CSE:COLOb): +2.07%, ending at 479.10
• Demant A/S (CSE:DEMANT): +1.80%, ending at 294.60

On the downside, jewelry maker Pandora A/S (CSE:PNDORA) was the biggest laggard, falling 2.16% to 851.20. Energy firm Oersted AS (CSE:ORSTED) declined 1.89%, while logistics group DSV Panalpina A/S (CSE:DSV) shed 1.17%.

Broader Market Context

In commodities, oil prices advanced, with Brent crude for November delivery rising 0.73% to $95.34 a barrel. In currency markets, the USD/DKK and EUR/DKK pairs were largely flat. The U.S. Dollar Index Futures, a measure of the dollar against a basket of currencies, edged down 0.17%.